Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Disposal

27 Apr 2006 17:09

Compagnie de Saint-Gobain27 April 2006 April 27, 2006 press release DISPOSAL OF SAINT-GOBAIN CALMAR Saint-Gobain has signed today an agreement regarding the sale of its subsidiarySaint-Gobain Calmar to MeadWestvaco Corporation. Calmar is a leading globalmanufacturer of plastic dispensing and spraying systems for cosmetics andfragrance, personal care as well as pharmaceutical industries. The transaction values Calmar at $745 million (of which $710 million in cashpaid by MeadWestvaco and $35 million of eliminated commitments by Saint-Gobain).In 2005, Calmar reported a pro-forma EBITDA of $72.7 million. Acquired by the Saint-Gobain Group in 1998, Calmar reported pro-forma sales of$403 million in 2005 and has approximately 2,700 employees based in 10production sites. Calmar will benefit from MeadWestvaco's financial capacity and global packagingstrategy, which should support its future development as a major player in itsbusiness. With annual revenues exceeding $6 billion, MeadWestvaco is a leading globalpackaging company that delivers high-value packaging solutions and products tocompanies in the food and beverage, media and entertainment, personal care,cosmetic and healthcare industries. MeadWestvaco employs approximately 23,000people around the world. The completion of the transaction, which is subject to the approval of therelevant anti-trust authorities, should be effective before the end of June2006. As it was communicated following the acquisition of BPB, the Saint-Gobain Groupis implementing a dynamic strategy of active portfolio management, consistentwith its business model. Investor Relations Department Mrs Florence TRIOU-TEIXEIRA Tel.: +33 1 47 62 45 19Mr Alexandre ETUY Tel.: +33 1 47 62 37 15 Fax.: +33 1 47 62 50 62 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Oct 20177:12 amRNSSaint-Gobain finalizes the acquisition of Glava
11th Oct 20177:14 amRNSAcquisition
29th Sep 20174:53 pmRNSShares cancelation
25th Aug 20174:23 pmRNSProspectus Supplement
27th Jul 20175:02 pmRNSHalf-year Report
25th Jul 20177:00 amRNSAcquisition
24th Jul 20177:23 amRNSAcquisition
13th Jul 20177:15 amRNScyber-attack update
12th Jul 20174:29 pmRNSProspectus
4th Jul 20177:00 amRNScyber-attack update
30th Jun 20177:09 amRNSAcquisition
26th Jun 20175:13 pmRNSNew facility
14th Jun 20175:07 pmRNSAcquisition
13th Jun 20176:22 pmRNSFinal Terms
8th Jun 20175:49 pmRNSAGM Statement
6th Jun 20178:48 amRNSGovernance
2nd Jun 20179:18 amRNSShare buy back
31st May 20174:57 pmRNSIssue of Debt
26th Apr 20174:56 pmRNS1st Quarter Results
6th Apr 20179:20 amRNSAcquisition
17th Mar 20171:31 pmRNSFinal Terms
6th Mar 20174:56 pmRNSSuccessfull launch of a bond offering
6th Mar 20179:30 amRNSStabilisation Notice
3rd Mar 20179:27 amRNSProspectus Supplement
2nd Mar 20175:22 pmRNSAcquisition in Southern Brazil
23rd Feb 20175:56 pmRNSAnnual Financial Report
24th Jan 20176:11 pmRNSConstruction Of a New Gypsum Plant In Vietnam
6th Dec 20168:35 amRNSAcquisition
4th Nov 20164:50 pmRNSAcquisition
2nd Nov 20167:14 amRNSAcquisition
31st Oct 20167:00 amRNSAcquisition
27th Oct 20166:15 pmRNS3rd Quarter Results
25th Oct 20165:44 pmRNSAcquisition
27th Sep 201611:44 amRNSFinal Terms
15th Sep 20165:41 pmRNSSaint-Gobain joins the DJ sustainability indexes
15th Sep 20163:25 pmRNSStabilisation Notice
15th Sep 20167:00 amRNSIssue of Debt
12th Sep 20165:55 pmRNSPublication of Suppl.Prospcts
28th Jul 20165:57 pmRNSHalf-year Report
28th Jul 20167:00 amRNSBase Prospectus
11th Jul 20164:47 pmRNSAcquisition
2nd Jun 20166:23 pmRNSAGM Statement
25th May 20165:00 pmRNSShares cancellation
4th May 20167:50 amRNSShares buy back
3rd May 20165:58 pmRNSShares buy back
3rd May 20167:00 amRNSAcquisition
27th Apr 20165:06 pmRNS1st Quarter Results
14th Mar 20169:05 amRNSAcquisition
11th Mar 20165:23 pmRNSProspectus Supplement
10th Mar 20164:38 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.